EcoDrugPlus

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSVPAG00000006074
Gene Symbol: ADH5
1 Cross references
401 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSVPAG00000010228
Gene Symbol: APCS
3 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSVPAG00000005253
Gene Symbol: APP
1 Cross references
276 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSVPAG00000002333
Gene Symbol: APH1B
1 Cross references
190 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSVPAG00000005083
Gene Symbol: APEX1
1 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSVPAG00000003577
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSVPAG00000004458
Gene Symbol: ALOX5AP
1 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSVPAG00000006941
Gene Symbol: AVPR1A
1 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSVPAG00000007689
Gene Symbol: AVPR1B
1 Cross references
134 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSVPAG00000008443
Gene Symbol: AHR
1 Cross references
154 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSVPAG00000009736
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSVPAG00000007217
Gene Symbol: AURKC
1 Cross references
96 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).